News & Events



Assay Development: Fundamentals and Practices

《 Assay Development: Fundamentals and Practices》 is new book that covers the essentials and techniques involved in carrying out an assay project in either a biotechnology/drug discovery setting or a platform setting. Rather than attempting comprehensive coverage of all assay development technologies, the book introduces the most widely used assay development technologies and illustrates the art of assay development through a few commonly encountered biological targets in assay development (e.g., proteases, kinases, ion channels, and G protein-coupled receptors). Just enough biological background for these biological targets is provided so that the reader can follow the logics of assay development. Chapters discuss:

- The basics of assay development, including foundational concepts and applications
- Commonly used instrumental methods for both biochemical assays and cell-based assays
- Assay strategies for protein binding and enzymatic activity
- Cell-based assays
- High-throughput screening

The author, Dr. Ge Wu, is currently the Director of Assay Development at Iris International. He obtained his doctorate in biochemistry from UCLA, performed postdoctoral work at Harvard Medical School, and was a member of the faculty at Cornell University Medical College. Prior to joining Iris International, he worked at Merck & Co., Caliper Technologies, Amphora Discovery, and FivePrime Therapeutics. He is the founding Director of Assay Development and Screening at FivePrime Therapeutics. Dr. Wu is a leading figure in assay development and screening in biopharmaceutical discovery using primary cell assay and the author of an acclaimed review in this subject.

中国《生物医药‘十二五’发展规划》即将出炉

肝癌致癌基因取得重大发现

南通大学举行《北美华人生物医药协会归国代表团演讲会》

BIO Welcomes Zhangjiang Hi-Tech Park and China Medical City

US-China Collaboration to battle the oil spill

Smart underpants become personal monitor

中国公布《国家中长期人才发展规划纲要》

中国重新强调科技创新“举国体制”

Pain, Adenosine and Acupuncture

苏州工业园区第三批生物医药领军人物

New tooth growing from stem cell

Charles River Plans to Acquire WuXi AppTec for 1.6 B

Page: 1 | 2 | 3 | 4 | 5 |